Mei Lu

Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population

M. Skup, J. Chao, R. Cross, 2016, Inflammatory bowel diseases.

Outcomes of COVID-19 in a Large Cohort of Lung Transplant Recipients: A Retrospective Study

D. Franco-Palacios, G. Alangaden, Mei Lu, 2022, Transplantology.

Inhibitor clinical burden of disease: a comparative analysis of the CHESS data

J. O’Hara, T. Kauf, A. Oladapo, 2018, Orphanet Journal of Rare Diseases.

Economic Burden Associated with Major Surgery in Patients with von Willebrand Disease: A United States Retrospective Administrative Database Analysis

S. Farahbakhshian, B. Ewenstein, A. Oladapo, 2021, Journal of blood medicine.

Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States

S. Farahbakhshian, B. Ewenstein, A. Oladapo, 2020, Journal of managed care & specialty pharmacy.

Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States

B. Goodwin, M. Vera‐Llonch, Mei Lu, 2021, Journal of clinical gastroenterology.

Prevalence and Characteristics of Dysphagia Based on a Population-Based Survey.

Christopher V. Almario, B. Spiegel, M. Vera‐Llonch, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Burden of cytopenias among myelofibrosis patients.

R. Mesa, J. Feliciano, Yoojung Yang, 2016 .

Observational Study of Treatment Patterns in Patients Newly Initiated with Adalimumab or Infliximab Therapy for Crohnʼs Disease: 1281

S. Plevy, J. Chao, P. Mulani, 2009 .